Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

X4 Pharmaceuticals, Inc. XFOR

Full chart Compare
Set alert

Price alert · XFOR

All alert types
3.14 USD +0.07 (+2.28%)

Nov 6, 2026, 2:02 PM EST

2.90 Day range 3.21
2.43 52-week range 4.83
YTD
-21.50%
1 year
-10.54%

Financial health

Altman Z-Score

-2.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-3 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 3

Valuation

P/E -2.1×
FY 2016: -1.5×FY 2017: -0.1×FY 2018: -0.0×FY 2019: -2.3×FY 2020: -2.1×FY 2021: -0.6×FY 2022: -0.7×FY 2023: -1.5×FY 2024: -3.9×FY 2025: -2.1×
FY 2016 5y median -1.5× FY 2025
P/S 4.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 43.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 57.7×FY 2025: 4.8×
FY 2016 5y median 0.0× FY 2025
P/B 0.9×
FY 2016: -2.0×FY 2017: 0.1×FY 2018: -0.1×FY 2019: 1.0×FY 2020: 1.8×FY 2021: 0.9×FY 2022: 0.9×FY 2023: 2.9×FY 2024: 6.7×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -1.9×
FY 2016: -1.5×FY 2017: -0.2×FY 2018: -0.0×FY 2019: -2.6×FY 2020: -2.1×FY 2021: -0.8×FY 2022: -0.8×FY 2023: -1.5×FY 2024: -1.1×FY 2025: -1.9×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA -0.4×
FY 2016: -1.9×FY 2017: 1.7×FY 2018: -0.1×FY 2019: -0.4×FY 2020: -1.5×FY 2021: -0.2×FY 2022: 0.2×FY 2023: -1.1×FY 2024: -6.2×FY 2025: -0.4×
FY 2016 5y median -0.4× FY 2025
EV/Sales 0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 29.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 66.4×FY 2025: 0.8×
FY 2016 5y median 0.0× FY 2025
FCF Yield -52.4%
FY 2016: -65.0%FY 2017: -636.6%FY 2018: -2388.1%FY 2019: -39.1%FY 2020: -46.6%FY 2021: -121.3%FY 2022: -122.4%FY 2023: -64.8%FY 2024: -93.7%FY 2025: -52.4%
FY 2016 5y median -93.7% FY 2025

Profitability

Gross Margin 82.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 59.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 68.8%FY 2025: 82.2%
FY 2016 5y median 0.0% FY 2025
Operating Margin -247.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -1995.8%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1423.6%FY 2025: -247.4%
FY 2016 5y median 0.0% FY 2025
Net Margin -225.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2071.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1464.6%FY 2025: -225.6%
FY 2016 5y median 0.0% FY 2025
ROE -42.5%
FY 2016: 137.4%FY 2017: -57.7%FY 2018: 285.0%FY 2019: -40.9%FY 2020: -85.3%FY 2021: -137.7%FY 2022: -126.8%FY 2023: -198.0%FY 2024: -169.1%FY 2025: -42.5%
FY 2016 5y median -137.7% FY 2025
ROIC -32.7%
FY 2016: -3585.6%FY 2017: -49.6%FY 2018: -781.0%FY 2019: -30.8%FY 2020: -53.6%FY 2021: -71.7%FY 2022: -64.5%FY 2023: -85.7%FY 2024: -31.7%FY 2025: -32.7%
FY 2016 5y median -64.5% FY 2025
ROA -27.3%
FY 2016: -302.1%FY 2017: -41.7%FY 2018: -334.7%FY 2019: -32.9%FY 2020: -50.6%FY 2021: -75.7%FY 2022: -60.3%FY 2023: -68.7%FY 2024: -25.6%FY 2025: -27.3%
FY 2016 5y median -60.3% FY 2025

Growth (YoY)

Revenue 1273.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 1273.2%
FY 2016 FY 2025
Operating Income -138.7%
FY 2016: -64.2%FY 2017: -48.4%FY 2018: 19.5%FY 2019: -60.9%FY 2020: -27.9%FY 2021: -25.8%FY 2022: -16.2%FY 2023: -22.8%FY 2024: 66.1%FY 2025: -138.7%
FY 2016 FY 2025
EPS (diluted) 66.5%
FY 2016: -37.2%FY 2017: -922.4%FY 2018: 19.9%FY 2019: 99.0%FY 2020: 33.2%FY 2021: -28.8%FY 2022: 61.9%FY 2023: 62.6%FY 2024: 67.3%FY 2025: 66.5%
FY 2016 FY 2025
Free Cash Flow 35.9%
FY 2016: -97.6%FY 2017: -28.6%FY 2018: 8.9%FY 2019: -89.7%FY 2020: -24.8%FY 2021: -18.8%FY 2022: -7.9%FY 2023: -25.1%FY 2024: -43.1%FY 2025: 35.9%
FY 2016 FY 2025

Financial Health

Current Ratio 10.2×
FY 2016: 0.5×FY 2017: 7.4×FY 2018: 1.2×FY 2019: 13.7×FY 2020: 7.0×FY 2021: 6.3×FY 2022: 5.8×FY 2023: 5.3×FY 2024: 3.4×FY 2025: 10.2×
FY 2016 5y median 5.8× FY 2025
Quick Ratio 10.0×
FY 2016: 0.5×FY 2017: 7.4×FY 2018: 1.2×FY 2019: 13.7×FY 2020: 7.0×FY 2021: 6.3×FY 2022: 5.8×FY 2023: 5.3×FY 2024: 3.3×FY 2025: 10.0×
FY 2016 5y median 5.8× FY 2025
Debt / Equity 0.4×
FY 2016: -0.9×FY 2017: 0.2×FY 2018: -0.8×FY 2019: 0.2×FY 2020: 0.5×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 1.1×FY 2024: 3.5×FY 2025: 0.4×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 2.0×
FY 2016: -0.5×FY 2017: 1.8×FY 2018: -0.1×FY 2019: 2.2×FY 2020: 0.7×FY 2021: 0.5×FY 2022: 0.9×FY 2023: 0.4×FY 2024: -0.8×FY 2025: 2.0×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -9.8×
FY 2016: -9.7×FY 2017: -17.4×FY 2018: -40.4×FY 2019: -21.8×FY 2020: -22.3×FY 2021: -20.7×FY 2022: -21.9×FY 2023: -18.6×FY 2024: -4.2×FY 2025: -9.8×
FY 2016 5y median -18.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31